Issue 004 | U.S. Pilot | US

SXTC

China SXT Pharmaceuticals, Inc.

Screen state: Needs Review Source state: Stale Filing 20-F | 2025-07-31 Filing currency: USD
Internal NCAV Discount 94.4%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
21,296,491USD
Total Liabilities
6,223,746USD
NCAV
15,072,745USD
Cash
18,099,019USD
NCAV per share
1.54USD/share
Evidence
7 annual | 13 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Evaluated
12
Triggered
5
Unavailable
0
Requires inspection Material 1Y Share Increase 13,763,268
Latest
13,763,2682025-03-31
Comparison
2,218,2062024-03-31
Change
+520.5%

Basis: 1Y share change >= +2% using the same share-count source

Source periods: SEC 20-F 2025-03-31 · 0001213900-25-069688; REPORTED_FILING 20-F 2024-03-31

Requires inspection Negative OCF -2,345,333
Latest
-2,345,3332025-03-31
Comparison
n/a
Change
n/a

Basis: latest reporting-period cash from operations < 0

Source periods: SEC 20-F 2025-03-31 · 0001213900-25-069688

Supporting observation NCAV Growing 15,072,745
Latest
15,072,7452025-03-31
Comparison
5,036,7482024-03-31
Change
+199.3%

Basis: equivalent prior-year NCAV change >= +2%; both NCAV values must be positive

Source periods: SEC 20-F 2025-03-31 · 0001213900-25-069688; REPORTED_FILING 20-F 2024-03-31

Supporting observation Low Debt 0.05
Latest
0.052025-03-31
Comparison
0.2
Change
n/a

Basis: (short-term debt + long-term debt) / ordinary equity < 20%

Source periods: SEC 20-F 2025-03-31 · 0001213900-25-069688

Supporting observation Current Ratio > 1.5 3.54
Latest
3.542025-03-31
Comparison
1.5
Change
n/a

Basis: current assets / current liabilities; strong if > 1.5

Source periods: SEC 20-F 2025-03-31 · 0001213900-25-069688

Business Profile

Published only when a substantive filing-text profile has been prepared for this issue.

Not available for this issue.

A substantive filing-text profile was not prepared for this company. Financial statement evidence and filing links remain available above for direct inspection.

Share Count & Per-Share Comparability

Data Vault has not published the normalized share-count artifact for this company.

Known Unknowns

Only 13 quarterly periods available from Data Vault for this company.

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Medium | Filing

Some rows are based on older filing data and require manual freshness review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-03-31
20-F
USD
2024-03-31
20-F
USD
2023-03-31
20-F
USD
2022-03-31
20-F
USD
2021-03-31
20-F
USD
2020-03-31
20-F
USD
2019-03-31
20-F
USD
Revenue 1,740,907 1,928,497 1,971,679 2,602,281 4,777,573 5,162,268 7,012,026
Operating Income -2,680,479 -2,515,217 -5,607,509 -5,189,673 -2,197,076 -1,341,117 1,769,492
Net Income -3,303,652 -3,098,532 -5,934,772 -5,736,095 -2,748,183 -10,287,872 1,539,227
Cash From Operations -2,345,333 -1,928,053 -80,757 268,293 -1,316,561 934,247 239,192
Capex n/a n/a n/a -60,932 -78,302 -130,839 -535,825
Free Cash Flow n/a n/a n/a 207,361 -1,394,863 803,408 -296,633
Cash And Equivalents 18,099,019 12,070,345 17,368,478 15,524,322 13,358,975 7,287,032 9,130,849
Accounts Receivable 1,301,335 1,314,781 1,344,569 3,333,178 4,507,115 3,819,437 4,180,559
Inventory 828,053 794,855 531,254 1,017,527 859,696 892,767 1,007,918
Total Current Assets 21,296,491 14,233,359 19,521,247 22,451,855 23,233,476 19,636,313 15,588,100
Total Assets 21,663,508 23,127,057 29,554,056 33,546,273 34,547,602 21,702,178 17,470,833
Total Current Liabilities 6,012,063 8,901,944 14,496,938 17,121,565 18,579,903 12,264,314 6,321,372
Total Liabilities 6,223,746 9,196,611 14,862,761 17,121,565 18,586,195 12,300,825 6,363,078
Shareholders Equity 15,439,762 13,930,446 14,691,295 16,424,708 15,961,407 9,401,353 11,107,755
Shares Outstanding 0 0 11,434,129 40,627,868 15,525,094 34,667,707 22,706,701
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 1,423,301 867,422 6,674,327 1,039,766 14,390,980 24,728,655 20,568,630
Weighted Avg Shares Basic 1,423,301 867,422 6,674,327 1,039,766 14,390,980 24,728,655 20,568,630
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Only 13 quarterly periods available from Data Vault for this company.

Metric
2024-09-30
6-K
USD
2024-03-31
6-K
USD
2023-09-30
6-K
USD
2023-03-31
6-K
USD
2022-09-30
6-K
USD
2022-03-31
6-K
USD
2021-09-30
6-K
USD
2021-03-31
6-K
USD
2020-09-30
6-K
USD
2020-03-31
6-K
USD
2019-09-30
6-K
USD
2019-03-31
6-K/A
USD
2018-09-30
6-K/A
USD
Revenue 829,490 1,928,497 939,583 1,971,679 1,208,288 2,602,281 1,027,674 4,777,573 3,860,501 5,162,268 3,215,147 7,012,026 3,917,707
Operating Income -638,267 -2,515,217 -9,349,021 -5,607,509 -1,150,446 -5,189,673 -2,891,527 -2,197,076 1,163,810 -1,341,117 -220,753 1,769,492 1,326,935
Net Income -802,568 -3,098,532 -9,696,158 -5,934,772 -1,494,609 -5,736,095 -3,091,824 -2,748,183 1,381,258 -10,287,872 -2,348,069 1,539,227 995,046
Cash From Operations -1,357,179 -1,928,053 -579,568 -80,757 -549,125 268,293 -312,349 -1,316,561 -333,508 934,247 -2,023,834 239,192 -467,819
Capex n/a n/a n/a n/a -20,115 -60,932 -21,137 -78,302 -4,931 -130,839 -123,543 -535,825 -84,402
Free Cash Flow n/a n/a n/a n/a -569,240 207,361 -333,486 -1,394,863 -338,439 803,408 -2,147,377 -296,633 -552,221
Cash And Equivalents 18,512,756 12,070,345 11,465,020 17,368,478 2,981,034 15,524,322 31,321 13,333,028 10,353,474 7,287,032 8,247,069 9,130,849 383,606
Total Current Assets 21,988,312 14,233,359 13,495,320 19,521,247 12,359,834 22,451,855 11,661,279 23,233,476 22,059,206 19,636,313 17,542,342 15,588,100 n/a
Total Liabilities 15,962,396 9,196,611 9,511,646 14,862,761 7,291,743 17,121,565 8,878,775 18,586,195 5,521,668 12,300,825 11,636,808 6,363,078 n/a
Shares Outstanding 3,906,471 3,906,471 727,851 457,365 3,612,885 2,031,394 16,870,238 15,525,094 62,057,584 34,667,707 23,224,866 22,706,701 n/a
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 3,231,357 867,422 501,467 6,674,327 102,316 1,039,766 777,465 719,549 14,390,101 309,108 22,725,512 20,568,630 20,000,000
Weighted Avg Shares Basic 3,231,357 867,422 501,467 6,674,327 102,316 1,039,766 777,465 719,549 14,390,101 309,108 22,725,512 20,568,630 20,000,000
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 21,988,312USD us-gaap:AssetsCurrent 2024-09-30 1.00 Data Vault | sec/companyfacts/cik=0001723980/companyfacts.json
Data Vault | sec/companyfacts/cik=0001723980/companyfacts.json
Total Liabilities 15,962,396USD us-gaap:Liabilities 2024-09-30 1.00 Data Vault | sec/companyfacts/cik=0001723980/companyfacts.json
Data Vault | sec/companyfacts/cik=0001723980/companyfacts.json
Cash 18,512,756USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2024-09-30 1.00 Data Vault | sec/companyfacts/cik=0001723980/companyfacts.json
Data Vault | sec/companyfacts/cik=0001723980/companyfacts.json
Shares Outstanding 3,906,471 us-gaap:CommonStockSharesOutstanding 2024-09-30 1.00 Data Vault | sec/companyfacts/cik=0001723980/companyfacts.json
Data Vault | sec/companyfacts/cik=0001723980/companyfacts.json
NCAV 6,025,916USD derived 2024-09-30 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 1.54USD derived 2024-09-30 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 94.4% derived 2024-09-30 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
Local evidence | The Data Vault
CIK
0001723980
Company ID
n/a
Selected Annual Source
Data Vault | sec/companyfacts/cik=0001723980/companyfacts.json
Selected Quarterly Source
Data Vault | sec/companyfacts/cik=0001723980/companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
14
Imported At
2026-08-09T01:58:15+00:00
Rendered At
2026-08-16T03:29:54+00:00

Run Audit

Mary Run
29510e1968ca4fb386d55ebe1e97a5de
Mary As Of
2026-08-01
Accession
0001213900-25-069688
CIK
0001723980
Mary Filing Date
2025-07-31
Filing Currency
USD
Internal Discount
94.4%
Source State
Stale Filing
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=29510e1968ca4fb386d55ebe1e97a5de; mary_as_of=2026-08-01; mary_filing_date=2025-07-31; mary_accession=0001213900-25-069688; mary_cik=0001723980; gnni_supporting_filing_date=2025-07-31; internal_discount=0.943569; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.; source requires review

Back to Register Report a correction Archive